Get started

Stockpicks

CEMI Technical Analysis 🧙Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
CLong
by trading_as_bus
$TKAT surged yesterday due to hype in NFT art?The Hong Kong-based online art trading platform rose prompted by increased attention from social media amid frenzy surrounding non-fungible tokens. NFTs are akin to a digital certificate of ownership. Takung provides collectors a way to jointly own Asian and other fine arts including paintings, calligraphies, jewelry, and precious gems, according to its website. The hype in NFT art ranging from sneakers to memes have been in the focus of late and a piece from Beeple — “The First 5000 Days” — commanded price tags of millions of dollars. Tesla Inc TSLA CEO Elon Musk also jumped on the bandwagon and put an NFT song — on NFTs — for sale, which the artist Beeple offered to purchase for $69 million, but later changed his mind. www.benzinga.com
T
by AlenCiken
$SVRA Announces Closing of $130 Million Public OfferingSavara Announces Pricing of Public Offering of Common Stock $SVRA today announced the pricing of an underwritten public offering of 45,785,828 shares of its common stock at a price to the public of $1.45 per share. As a component of the offering, in lieu of shares of common stock, Savara offered to certain existing investors pre-funded warrants to purchase an aggregate of 32,175,172 shares of common stock at a purchase price of $1.449 per warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each pre-funded warrant. finance.yahoo.com Savara Announces Closing of $130 Million Public Offering Following Full Exercise of Underwriters’ Option finance.yahoo.com
NASDAQ:SVRA
by AlenCiken
NIKE Stock 16/03/21 Analysis 4H ChartNYSE:NKE - Trend Analysis - 📑Value: 0/20 📈Growth: 18/20 💰Profitability: 20/20 🚀Momentum: 8/20 💸Earnings: 16/20 🖇️Total Score: 62/100 Analysis: Low: $41 Average: $72.83 High: $105 Current: $72.96 Data: Volume 3.74M Average Volume (3 months) 5.71M Previous Close $144.94 Open $145.88 Shares Outstanding 1.27B Technicals: (Simple Moving Average) 10D SMA $137.13 (+5.55%) 50D SMA $139.63 (+3.67) 200D SMA $122.39 (+18.27%) Market Cap $221.42B Total Debt $12.80B Cash $11.81B Enterprise Value $222.41B Dividend Yield 0.76% Annual Payout $1.10 Payout Ratio 36.88% Years of Growth 19 Years Latest Announced Dividend $0.28 Ex-Dividend Date 26/02/2021 Payout Date 01/04/2021 Revenue $38.25B Gross Profit $16.44B Net Income $2.83B EPS Diluted $1.77 Free Cash Flow / Share $2.32
NYSE:NKELong
by investor_kings
$QS PT 120 and higherQuantumScape, a developer of what are known as solid-state batteries, has entered into a definitive agreement to merge with blank check company Kensington Capital Acquisition Corp. EV battery manufacturer backed by Bill Gates and Volkswagen. Implied Value of combined companies is $3.3B QuantumScape Corporation engages in the development and commercialization of solid-state lithium-metal batteries for electric vehicles. The company was founded in 2010 and is headquartered in San Jose, California
NYSE:QSLong
by BADQOMOCAWGOWLD
1
DKNG Stock 12/03/21 Analysis 4H Chart(DRAFTKINGS: DKNG ) - Trend Analysis - 📑Value: 0/20 📈Growth: 14/20 💰Profitability: 14/20 🚀Momentum: 20/20 💸Earnings: 14/20 🖇️Total Score: 62/100 Analysis: Low: $41 Average: $72.83 High: $105 Current: $72.96 Income Statement: Revenue: $614.53M Gross Profit: $267.94M EBITDA: ----- Net Income: ----- EPS Diluted: -$2.76 Cash Flow Statement: Cash from Operations: -$337.88M Cash from Investing: -$227.34M Levered Free Cash Flow: -$49.38M Unlevered Free Cash Flow: -$48.72M Free Cash Flow: -$1.26 Balance Sheet: Total Cash: $1.82B Total Debt: $81.61M Total Debt to Equity: 3.03% Current Ratio: 3.96 Quick Ratio: 3.96
NASDAQ:DKNGLong
by investor_kings
$SEEL PT 90 and higherSeelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing of novel technologies and therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorder and post-traumatic stress disorder; SLS-005, a protein stabilizer for the treatment of Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
SLong
by BADQOMOCAWGOWLD
$EEENF PT 5 Supernova 285X Returns88 Energy Limited (ASX:88E; AIM 88E) has just commenced drilling the Merlin-1 well which will initially be drilled to 1,500 feet, then surface casing will be installed and the Blow Out Preventer System tested. This is expected to take approximately one week to execute after which the well will be deepened through the target horizons in the Nanushuk Formation to a maximum total depth of 6,000 feet. The Merlin-1 well is targeting 645 million barrels of gross mean prospective resource as outlined below. Logging while drilling and mudlogging will provide initial indications as to the prospectivity of the well during this part of the operation which is expected to take three to five days. A sophisticated wireline logging suite will then be run, including sidewall cores and downhole sampling. Wireline logging is expected to take five to seven days. If the results from the wireline logging are encouraging, then the well will be completed with casing and a flow test conducted. US$13 million in cash to pursue Harrier-1 next season 88E said that recent delays commencing Merlin-1 could well result in the previously planned Harrier-1 not being drilled until next season. There has also been a financial impact from delays mainly associated with the issuance of a permit to drill that should see the costs of the well attributed to 88E increasing from US$1.4 million to US$4 million. Notwithstanding this financial impost, the company’s current cash position is US$13 million which more than funds its share of the drilling of Merlin-1 and the company’s other planned activities. Consequently, management’s focus is firmly on achieving success with Merlin-1, and on this note managing director Dave Wall said, "Drilling has now commenced at Merlin-1, with results expected within the next 4 weeks. "This is an exciting and pivotal time for the company and our shareholders.” The timing of a potential oil strike couldn’t be better with the Crude Oil WTI Index hitting a high of US$67.98 per barrel just last week, a level it hasn’t traded at since 2018.
OTC:EEENF
by BADQOMOCAWGOWLD
7
SBUX Stock 11/03/21 Analysis 4H ChartNASDAQ:SBUX (STARBUCKS: SBUX ) - Trend Analysis - 📑Value: 6/20 📈Growth: 20/20 💰Profitability: 14/20 🚀Momentum: 8/20 💸Earnings: 16/20 🖇️Total Score: 64/100 Analysis: Low: $82 Average: $109.53 High: $125 Current: $107.59 Income Statement: Revenue: $23.17B Gross Profit: $4.93B EBITDA: $2.87B Net Income: $664.80M EPS Diluted: $0.57 Cash Flow Statement: Cash from Operations: $1.60B Cash from Investing: $1.60B Levered Free Cash Flow: $419.84M Unlevered Free Cash Flow: $128.71M Free Cash Flow: $0.16 Balance Sheet: Total Cash: $5.26B Total Debt: $24.98B Total Debt to Equity: Current Ratio: 1.06 Quick Ratio: 0.84
NASDAQ:SBUXLong
by investor_kings